mesalamine has been researched along with Intracranial Hypertension in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Intracranial Hypertension: Increased pressure within the cranial vault. This may result from several conditions, including HYDROCEPHALUS; BRAIN EDEMA; intracranial masses; severe systemic HYPERTENSION; PSEUDOTUMOR CEREBRI; and other disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martín Rodríguez, MM | 1 |
| Ruiz-Cabello Jiménez, M | 1 |
| Gómez García, M | 1 |
| Vega Villaamil, P | 1 |
| González Castillo, S | 1 |
1 other study available for mesalamine and Intracranial Hypertension
| Article | Year |
|---|---|
[Benign intracranial hypertension and ulcerative colitis].
Topics: Acetazolamide; Adult; Anti-Inflammatory Agents, Non-Steroidal; Carbonic Anhydrase Inhibitors; Coliti | 2007 |